Rizwan Bukhari, MD
Vascular Surgery · Mesquite, TXNPI 1225076227
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (58.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 65.9% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $30,138, more than ten times the $271 reported in 2019.
Across 158 payments — averaging $283.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$29K
- Abbott$12K
- Endologix LLC$727
- Cardiovascular Systems Inc.$503
- Stryker$299
- Inari Medical, Inc.$221
- plus $1K from 16 others
Across 3 payments — averaging $33,325 each. An ownership or investment interest held by the physician or an immediate family member.
- Vasorum USA Inc.$100K
What the payments were for
- Consulting fees$10,92524%
- Travel & lodging$1,5323%
- Food & beverage$6,07814%
- Education$460%
- Other$26,16758%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 24 | $29,494 |
| Abbott | 61 | $12,500 |
| Endologix LLC | 6 | $727 |
| Cardiovascular Systems Inc. | 24 | $503 |
| Stryker | 5 | $299 |
| Inari Medical, Inc. | 4 | $221 |
| Bolton Medical Inc | 4 | $216 |
| Medtronic | 4 | $132 |
| Cordis US CORP. | 7 | $124 |
| Veryan Medical Incorporated | 1 | $98 |
| Johnson & Johnson | 3 | $70 |
| Shockwave Medical, Inc | 4 | $68 |
| Integra Lifesciences Corporation | 2 | $48 |
| Henry Schein, Inc. | 1 | $42 |
| Vasorum USA Inc. | 1 | $40 |
| Biotissue Holdings Inc. | 1 | $30 |
| Philips North America LLC | 1 | $27 |
| Innovation Technologies Inc | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $23 |
| Cvrx, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $20 |
| Ossur Americas, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$26,627
- SUPERA$10,925
- AngioVac$1,781
- AlphaVac$589
- ENDOCROSS Device$286
- Torus Stent Graft System$286
- FLOWTRIEVER CATHETER, S$283
- CT THROMBECTOMY SYSTEM KIT$283
- ALTO$269
- Ovation$269
- Diamondback Peripheral$247
- Perclose ProGlide suture mediated closure system$161
How this compares
$44,747 in reported general payments places this provider in the 85th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 15 | $18,206 |
| ClopidogrelClopidogrel Bisulfate | 86 | $674 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $70 | $18,20615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Mesquite
- Tammam ObeidMesquite$38K
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.